COSCIENS Biopharma Inc. (CSCI) — Cash Flow Reinvestment Rate
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow Reinvestment Rate of 0.52x as of September 2023, reinvesting $75.15K (capex $8.92K plus investments $-66.24K) from operating cash flow of $144.00K. See CSCI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Cash Flow Reinvestment Rate (2003–2022)
Historical reinvestment intensity for COSCIENS Biopharma Inc. across 13 annual periods. For the full cash flow conversion analysis, see COSCIENS Biopharma Inc. (CSCI) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year capital reinvestment analysis for COSCIENS Biopharma Inc.. See CSCI financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $399.39K | $5.23 Million | $10.57K | ▼ -84.4% |
| 2021 | 0.49x | $1.35 Million | $2.75 Million | $555.99K | ▲ +76.2% |
| 2020 | 0.28x | $969.60K | $3.49 Million | $485.46K | ▲ +5372320.5% |
| 2019 | 0.00x | $3.49 | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $3.20 Million | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.71 Million | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $3.03 Million | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $3.98 Million | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $2.16 Million | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $123.30K | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $85.01K | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $66.73K | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $103.05K | $54.42K | $103.05K | — |